VG Life Sciences Granted Key Composition of Matter Patent
02. März 2015 10:04 ET
|
VG Life Sciences
SANTA BARBARA, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., (OTCQB:VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, announced that the...
VG Life Sciences Announces Issuance of Patent Covering Treatment of Inflammatory Bowel Disease with Clip-Inducing Agent
29. Januar 2015 09:12 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent...
VGLS Q4 2014 Shareholder Update Letter
14. Januar 2015 10:13 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Jan. 14, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. releases a Q4 2014 Shareholder Update Letter:
January 14, 2015
Dear Shareholders,
Here at VG Life Sciences, our...
New Data Implicate Components of Adaptive Immunity in Traumatic Brain Injury
20. Oktober 2014 08:07 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc., (OTCQB:VGLS) a biotechnology company, announces today that one of its scientific advisors, Dr. Richard Tobin, PhD,...
VG Life Sciences Inc. Announces Upgrading to OTCQB Marketplace
16. Oktober 2014 18:02 ET
|
VG Life Sciences
SANTA BARBARA, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. (OTCQB: VGLS) is a biotechnology company focused on developing treatments for patients suffering from autoimmune and...
VG LIFE SCIENCES, INC. ANNOUNCES SEC FORM 10 REVIEW COMPLETE
14. Oktober 2014 16:41 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Oct. 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from...
VG Life Sciences' Advisor Gives Preeclampsia Presentation at American Heart Association Conference
12. September 2014 08:42 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Sept. 12, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces that one of its scientific advisors, Dr. Brett Mitchell, PhD, will give...
VG Life Sciences Inc. Progress Update Phase I Cancer Study
04. September 2014 08:07 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its physician-initiated IND phase I study to test...
VG Life Sciences, Inc. Announces Filing of Form 10 with the SEC.
23. Juni 2014 16:48 ET
|
VG Life Sciences
SANTA BARBARA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from...
Q1 2014 Shareholder Update Letter
13. Mai 2014 11:13 ET
|
VG Life Sciences
SANTA BARBARA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. releases a Q1 2014 Shareholder Update Letter:
May 13, 2014
Dear Shareholders,
Here at VG Life Sciences, our goal...